Colorectal cancer, or CRC, is the world's second most lethal cancer based on the number of deaths, and is the third most ...

In a trailblazing advancement in cancer therapy, researchers at Korea Advanced Institute of Science and Technology (KAIST) have developed a technology that transforms colon cancer cells into ...

Polish scientists have developed and tested a chemical compound that shows strong activity against colorectal cancer cells ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the ...

FDA approves CBI-1214 for colorectal cancer, enabling fast-tracked clinical trials and highlighting innovative T-cell engager ...

A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them, thus avoiding side ...

Circulating tumor cells (CTCs) have been detected in patients with a variety of solid tumors and may be predictive of prognosis. Although the US Food and Drug Administration has approved some methods ...

The results of the study could improve immunotherapy treatment for patients with colorectal and other barrier-tissue cancers.

Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and leading causes of cancer-related death worldwide. One critical factor that makes treating colon ...

Colon Cancer, also referred to as “colorectal” cancer, still ranks among the major challenges to humanity because it affects ...